• LAST PRICE
    0.4400
  • TODAY'S CHANGE (%)
    Trending Up0.0190 (4.5131%)
  • Bid / Lots
    0.4305/ 10
  • Ask / Lots
    0.4666/ 2
  • Open / Previous Close
    0.4304 / 0.4210
  • Day Range
    Low 0.4300
    High 0.4700
  • 52 Week Range
    Low 0.3720
    High 4.0377
  • Volume
    111,946
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.421
TimeVolumeRNLX
09:32 ET3480.4304
09:42 ET51250.43
09:55 ET5000.4395
10:06 ET33390.4394
10:09 ET5000.4394
10:22 ET60000.438331
10:26 ET1320.4394
10:31 ET2460.4305
10:40 ET1250.432361
11:02 ET32580.446
11:03 ET3000.44
11:05 ET24490.4598
11:07 ET56000.4692
11:09 ET2500.46
11:14 ET446250.4598
11:25 ET35700.4666
11:52 ET10000.45
12:10 ET1000.45
12:19 ET10000.45166
12:57 ET1000.46
01:24 ET4950.4559
01:36 ET8000.4598
01:47 ET1850.4501
01:56 ET1000.45
02:00 ET1000.4501
02:03 ET1890.4598
02:16 ET2000.4599
02:27 ET1000.4502
02:56 ET6480.459799
03:08 ET20980.4504
03:19 ET44510.46435
03:37 ET19800.4502
03:39 ET138310.45
03:42 ET26700.45
03:46 ET13000.45
03:53 ET4000.45
04:00 ET10000.44
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRNLX
Renalytix PLC
19.6M
-0.4x
---
United StatesADMT
ADM Tronics Unlimited Inc
6.8M
-12.5x
---
United StatesRDGL
Vivos Inc
19.5M
-7.6x
---
United StatesPOSC
Positron Corp
27.2M
-17.6x
---
United StatesPAVM
PAVmed Inc
23.3M
-0.3x
---
United StatesCSOC
Caduceus Software Systems Corp
15.3M
-47.6x
---
As of 2023-12-08

Company Information

Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company. The Company is focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Its diagnostic platform, KidneyIntelX, is designed to scale across kidney disease conditions beyond diabetic kidney disease. KidneyIntelX is a bioprognostic methodology. The Company is evaluating a range of new indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations, and coronavirus disease (COVID)-related kidney disease. KidneyIntelX platform facilitates the identification and promotes the effective management of patients at risk of early-stage diabetic kidney disease (DKD), progression by combining diverse data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record (HER) using a proprietary algorithm to generate a unique patient risk score.

Contact Information

Headquarters
Finsgate, 5-7 Cranwood StreetLONDON, United Kingdom EC1V 9EE
Phone
292-071-0570
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$19.6M
Revenue (TTM)
$2.9M
Shares Outstanding
48.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.19
EPS
$-1.01
Book Value
$0.15
P/E Ratio
-0.4x
Price/Sales (TTM)
6.8
Price/Cash Flow (TTM)
---
Operating Margin
-1,361.49%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.